Company Name: Pulmatrix Inc.
Pulmatrix Inc. is a clinical stage biopharmaceutical company. The company is engaged in the development of inhaled therapies designed to treat serious pulmonary diseases. The company’s developmental pipeline includes product candidates for cystic fibrosis (CF), idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD).
Ticker Symbol: PULM (NASDAQ)
Company Website: http://pulmatrix.com
Headquarters: Lexington, MA